Results 111 to 120 of about 1,552,989 (147)

Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CL^pro: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis. [PDF]

ACS Pharmacol Transl Sci
Lueangaramkul V, Mana N, Thangthamniyom N, Semkum P, Lekcharoensuk P, Limprasutr V, Theerawatanasirikul S.   +6 more
europepmc   +1 more source

Differential induction of PD-L1 expression in cells infected with feline infectious peritonitis virus and feline enteric coronavirus. [PDF]

Virology
Zabiegala A, Kim Y, Chang KO.
europepmc   +1 more source

In Vivo Antiviral Effects of U18666A Against Type I Feline Infectious Peritonitis Virus. [PDF]

Pathogens, 2020
Doki T, Tarusawa T, Hohdatsu T, Takano T.   +3 more
europepmc   +1 more source

GS-441524 Treatment in a Cat With Feline Infectious Peritonitis Virus and Pyogranulomatous Transverse Colon Lesion. [PDF]

In Vivo
Kim TY, Oh YI.
europepmc   +1 more source

In Vitro Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles against Feline Infectious Peritonitis Virus and Pharmacokinetics Study in Cats. [PDF]

Biomed Res Int, 2020
Ng SW, Selvarajah GT, Hussein MZ, Yeap SK, Omar AR.   +4 more
europepmc   +1 more source

Antiviral and Immunomodulatory Effects of α-Mangostin Against Feline Infectious Peritonitis Virus: In Vitro Assay. [PDF]

Animals (Basel)
Lueangaramkul V, Termthongthot P, Mana N, Panichayupakaranant P, Semkum P, Lekcharoensuk P, Theerawatanasirikul S.   +6 more
europepmc   +1 more source

Colony Stimulating Factors in Early Feline Infectious Peritonitis Virus Infection of Monocytes and in End Stage Feline Infectious Peritonitis; A Combined In Vivo And In Vitro Approach. [PDF]

Pathogens, 2020
Malbon AJ, Michalopoulou E, Meli ML, Barker EN, Tasker S, Baptiste K, Kipar A.   +6 more
europepmc   +1 more source

In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus. [PDF]

Antiviral Res, 2020
Theerawatanasirikul S, Kuo CJ, Phetcharat N, Lekcharoensuk P.   +3 more
europepmc   +1 more source

Correction: Development and characterization of reverse genetics systems of feline infectious peritonitis virus for antiviral research. [PDF]

Vet Res
Gu G, Fung TS, Hung WT, Osterrieder N, Go YY.   +4 more
europepmc   +1 more source

Identification of potential inhibitors of the main protease from feline infectious peritonitis virus using molecular docking and dynamic simulation approaches. [PDF]

PeerJ
Khan MY, Shah AU, Duraisamy N, Moawad N, ElAlaoui RN, Cherkaoui M, Hemida MG.   +6 more
europepmc   +1 more source